FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282840838> ?p ?o ?g. }

• W4282840838 endingPage "3395" @default.
• W4282840838 startingPage "3395" @default.
• W4282840838 abstract "The aim of this study was to determine the serum profiles of miRNAs in patients with tuberous sclerosis (TSC) upon sirolimus treatment and compare them with those previously treated with everolimus in a similarly designed experiment. Serum microRNA profiling was performed in ten TSC patients before sirolimus therapy and again after 3-6 months using qPCR panels (Exiqon). Of 752 tested miRNAs, 28 showed significant differences in expression between TSC patients before and after sirolimus treatment. Of these, 11 miRNAs were dysregulated in the same directions as in the sirolimus groupcompared with the previously described everolimus group, miR-142-3p, miR-29c-3p, miR-150-5p, miR-425-5p, miR-376a-3p, miR-376a-3p, miR-532-3p, and miR-136-5p were upregulated, while miR-15b-3p, miR-100-5p, and miR-185-5p were downregulated. The most significant changes of expression, with fold changes exceeding 1.25 for both treatments, were noted for miR-136-5p, miR-376a-3p, and miR-150-5p. The results of a pathway analysis of the possible target genes for these miRNAs indicated the involvement of the Ras and MAPK signaling pathway. Upregulation of miR-136, miR-376a-3p, and miR-150-5p was noted in TSC patients treated with mTOR inhibitors, indicating a role in the downregulation of the mTOR pathway. Further studies are needed to determine the relationship between upregulated microRNAs and treatment efficacy." @default.
• W4282840838 created "2022-06-15" @default.
• W4282840838 creator A5004662081 @default.
• W4282840838 creator A5005178459 @default.
• W4282840838 creator A5005801531 @default.
• W4282840838 creator A5011329647 @default.
• W4282840838 creator A5017404016 @default.
• W4282840838 creator A5018977084 @default.
• W4282840838 creator A5028077452 @default.
• W4282840838 creator A5035974730 @default.
• W4282840838 creator A5039789844 @default.
• W4282840838 creator A5046777203 @default.
• W4282840838 creator A5062036105 @default.
• W4282840838 date "2022-06-13" @default.
• W4282840838 modified "2023-10-18" @default.
• W4282840838 title "mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile" @default.
• W4282840838 cites W1993431258 @default.
• W4282840838 cites W1998203489 @default.
• W4282840838 cites W2015284016 @default.
• W4282840838 cites W2016682723 @default.
• W4282840838 cites W2050790870 @default.
• W4282840838 cites W2126467306 @default.
• W4282840838 cites W2128108497 @default.
• W4282840838 cites W2156198853 @default.
• W4282840838 cites W2157793936 @default.
• W4282840838 cites W2183032103 @default.
• W4282840838 cites W2195482268 @default.
• W4282840838 cites W2261734561 @default.
• W4282840838 cites W2461990664 @default.
• W4282840838 cites W2526093105 @default.
• W4282840838 cites W2606451514 @default.
• W4282840838 cites W2763901873 @default.
• W4282840838 cites W2894432237 @default.
• W4282840838 cites W2897825874 @default.
• W4282840838 cites W2903787573 @default.
• W4282840838 cites W2993520347 @default.
• W4282840838 cites W2995107420 @default.
• W4282840838 cites W2997325586 @default.
• W4282840838 cites W3021221360 @default.
• W4282840838 cites W3087916783 @default.
• W4282840838 cites W3090303464 @default.
• W4282840838 cites W3177858820 @default.
• W4282840838 cites W3193374952 @default.
• W4282840838 cites W3200327654 @default.
• W4282840838 cites W4212918676 @default.
• W4282840838 doi "https://doi.org/10.3390/jcm11123395" @default.
• W4282840838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35743464" @default.
• W4282840838 hasPublicationYear "2022" @default.
• W4282840838 type Work @default.
• W4282840838 citedByCount "3" @default.
• W4282840838 countsByYear W42828408382022 @default.
• W4282840838 countsByYear W42828408382023 @default.
• W4282840838 crossrefType "journal-article" @default.
• W4282840838 hasAuthorship W4282840838A5004662081 @default.
• W4282840838 hasAuthorship W4282840838A5005178459 @default.
• W4282840838 hasAuthorship W4282840838A5005801531 @default.
• W4282840838 hasAuthorship W4282840838A5011329647 @default.
• W4282840838 hasAuthorship W4282840838A5017404016 @default.
• W4282840838 hasAuthorship W4282840838A5018977084 @default.
• W4282840838 hasAuthorship W4282840838A5028077452 @default.
• W4282840838 hasAuthorship W4282840838A5035974730 @default.
• W4282840838 hasAuthorship W4282840838A5039789844 @default.
• W4282840838 hasAuthorship W4282840838A5046777203 @default.
• W4282840838 hasAuthorship W4282840838A5062036105 @default.
• W4282840838 hasBestOaLocation W42828408381 @default.
• W4282840838 hasConcept C104317684 @default.
• W4282840838 hasConcept C126322002 @default.
• W4282840838 hasConcept C127561419 @default.
• W4282840838 hasConcept C142724271 @default.
• W4282840838 hasConcept C143998085 @default.
• W4282840838 hasConcept C145059251 @default.
• W4282840838 hasConcept C183713625 @default.
• W4282840838 hasConcept C2777921159 @default.
• W4282840838 hasConcept C2778980267 @default.
• W4282840838 hasConcept C2779699572 @default.
• W4282840838 hasConcept C502942594 @default.
• W4282840838 hasConcept C54355233 @default.
• W4282840838 hasConcept C57074206 @default.
• W4282840838 hasConcept C62478195 @default.
• W4282840838 hasConcept C71924100 @default.
• W4282840838 hasConcept C86554907 @default.
• W4282840838 hasConcept C86803240 @default.
• W4282840838 hasConcept C95444343 @default.
• W4282840838 hasConceptScore W4282840838C104317684 @default.
• W4282840838 hasConceptScore W4282840838C126322002 @default.
• W4282840838 hasConceptScore W4282840838C127561419 @default.
• W4282840838 hasConceptScore W4282840838C142724271 @default.
• W4282840838 hasConceptScore W4282840838C143998085 @default.
• W4282840838 hasConceptScore W4282840838C145059251 @default.
• W4282840838 hasConceptScore W4282840838C183713625 @default.
• W4282840838 hasConceptScore W4282840838C2777921159 @default.
• W4282840838 hasConceptScore W4282840838C2778980267 @default.
• W4282840838 hasConceptScore W4282840838C2779699572 @default.
• W4282840838 hasConceptScore W4282840838C502942594 @default.
• W4282840838 hasConceptScore W4282840838C54355233 @default.
• W4282840838 hasConceptScore W4282840838C57074206 @default.
• W4282840838 hasConceptScore W4282840838C62478195 @default.
• W4282840838 hasConceptScore W4282840838C71924100 @default.

• next